Menu
Recruiting NCT07052604

Antibiotic Treatment for Pneumonia Caused by Stenotrophomonas Maltophilia in ICU Patients

— Observational Pneumonia, Ventilator-Associated Stenotrophomonas Maltophilia Intensive Care Units Anti-Bacterial Agents

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Pneumonia, Ventilator-Associated, Stenotrophomonas Maltophilia, Intensive Care Units, Anti-Bacterial Agents. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
France
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Overview

This study looks at how different antibiotic treatments affect patients in intensive care who have pneumonia caused by the bacteria Stenotrophomonas maltophilia. It compares using one antibiotic versus two antibiotics, and treatment lengths of 7 days versus 14 days, to see which approach helps patients survive better. The study also examines how resistant the bacteria are to antibiotics and how often the pneumonia comes back.

Primary outcome measures

  • patient survival based on the antibiotic treatment strategy used (monotherapy vs. combination therapy and 7 vs. 14 days duration). [Time frame: 28 days]

Eligibility criteria

Inclusion criteria

  • Adult patients (age ≥ 18 years)
  • Hospitalized in Medical Intensive Care Unit between January 1, 2018, and December 31, 2023
  • Intubated and mechanically ventilated
  • Diagnosed with ventilator-associated pneumonia caused by Stenotrophomonas maltophilia

Exclusion criteria

  • Patients under 18 years old
  • Patients who refuse the use of their data for research purposes

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Study design

Observational model
Cohort

Study locations

France · 1 center
  • Centre Hospitalier de Saint-Denis — Saint-Denis

Identifiers

NCT: NCT07052604 · 0055_STENO

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗